DBV Technologies Stock (NASDAQ: DBVT) stock price, news, charts, stock research, profile.
You can purchase shares of DBV Technologies (NASDAQ:DBVT) through any online brokerage.
Other companies in DBV Technologies’s space includes: Kezar Life Sciences (NASDAQ:KZR), Connect Biopharma Hldgs (NASDAQ:CNTB), Monopar Therapeutics (NASDAQ:MNPR), Immuneering (NASDAQ:IMRX) and Aligos Therapeutics (NASDAQ:ALGS).
DBV Technologies has a consensus price target of $4.33.
The stock price for DBV Technologies (NASDAQ: DBVT) is $0.6468 last updated November 13, 2024 at 9:20 AM EST.
There are no upcoming dividends for DBV Technologies.
DBV Technologies’s Q3 earnings are confirmed for Wednesday, November 6, 2024.
There is no upcoming split for DBV Technologies.
DBV Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.